Search Results 511-520 of 37874 for Two-phase

1. Rectal cancer - Survival rates - Mayo Clinic

   Localized cancer is considered early-stage cancer and includes stages 0, 1 and most stage 2 colorectal cancers. Survival rate for people with localized ...

2. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia) - Mayo Clinic

   The Stage 2 portion will enroll up to 18 patients with each of the 4 myeloproliferative malignancies: SM, PED, MF, and CMML. In entirety, the Stage 2 portion ...

3. Neurology - Clinical trials - Mayo Clinic

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

4. Study of RP-6306 With FOLFIRI in Advanced Solid Tumors - Mayo Clinic

   Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

5. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

6. Infant development: Birth to 3 months - Mayo Clinic

   But the way new babies communicate their needs is mostly by crying. By age 2 months, your baby might coo and repeat vowel sounds when you talk or gently play ...

7. Study Of Datopotamab Deruxtecan Plus Carboplatin Or Cisplatin Versus Gemcitabine Plus Carboplatin Or Cisplatin In Participants With Locally Advanced Or Metastatic Urothelial Carcinoma - Mayo Clinic

   About this study. This is a global, multicenter, randomized, open-label, Phase 2/3 study of Dato-DXd plus carboplatin or cisplatin versus gemcitabine plus ...

8. Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 - Mayo Clinic

   2. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

9. Publications - James W. Jakub, M.D. - Mayo Clinic

   Prepectoral Two-Stage Implant-Based Breast Reconstruction with and without Acellular Dermal Matrix: Do We See a Difference? Plast Reconstr Surg. 2020 Feb ...

10. Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - Mayo Clinic

    ... Phase 1a dose finding study (TARA-002-101-Ph1a). This Phase 2 study includes participants with CIS NMIBC (± Ta/T1) with active disease (defined as disease ...